| UniProt ID | ZNRF2_HUMAN | |
|---|---|---|
| UniProt AC | Q8NHG8 | |
| Protein Name | E3 ubiquitin-protein ligase ZNRF2 | |
| Gene Name | ZNRF2 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 242 | |
| Subcellular Localization |
Endosome membrane Peripheral membrane protein . Lysosome membrane Peripheral membrane protein . Cell junction, synapse, presynaptic cell membrane Peripheral membrane protein . Present in presynaptic plasma membranes in neurons. |
|
| Protein Description | May play a role in the establishment and maintenance of neuronal transmission and plasticity via its ubiquitin ligase activity. E3 ubiquitin ligases accept ubiquitin from an E2 ubiquitin-conjugating enzyme in the form of a thioester and then directly transfer the ubiquitin to targeted substrates.. | |
| Protein Sequence | MGAKQSGPAAANGRTRAYSGSDLPSSSSGGANGTAGGGGGARAAAAGRFPAQVPSAHQPSASGGAAAAAAAPAAPAAPRSRSLGGAVGSVASGARAAQSPFSIPNSSSGPYGSQDSVHSSPEDGGGGRDRPVGGSPGGPRLVIGSLPAHLSPHMFGGFKCPVCSKFVSSDEMDLHLVMCLTKPRITYNEDVLSKDAGECAICLEELQQGDTIARLPCLCIYHKGCIDEWFEVNRSCPEHPSD | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 2 | Myristoylation | ------MGAKQSGPA ------CCCCCCCCC | 41.29 | 14561866 | |
| 6 | Phosphorylation | --MGAKQSGPAAANG --CCCCCCCCCCCCC | 46.14 | - | |
| 15 | Phosphorylation | PAAANGRTRAYSGSD CCCCCCCCCCCCCCC | 22.50 | 23401153 | |
| 18 | Phosphorylation | ANGRTRAYSGSDLPS CCCCCCCCCCCCCCC | 15.41 | 30278072 | |
| 19 | Phosphorylation | NGRTRAYSGSDLPSS CCCCCCCCCCCCCCC | 30.73 | 19664994 | |
| 21 | Phosphorylation | RTRAYSGSDLPSSSS CCCCCCCCCCCCCCC | 29.99 | 22167270 | |
| 25 | Phosphorylation | YSGSDLPSSSSGGAN CCCCCCCCCCCCCCC | 50.58 | 30278072 | |
| 26 | Phosphorylation | SGSDLPSSSSGGANG CCCCCCCCCCCCCCC | 26.95 | 29978859 | |
| 27 | Phosphorylation | GSDLPSSSSGGANGT CCCCCCCCCCCCCCC | 37.02 | 23927012 | |
| 28 | Phosphorylation | SDLPSSSSGGANGTA CCCCCCCCCCCCCCC | 43.10 | 23927012 | |
| 34 | Phosphorylation | SSGGANGTAGGGGGA CCCCCCCCCCCCHHH | 23.18 | 23927012 | |
| 60 | Phosphorylation | VPSAHQPSASGGAAA CCCCCCCCCCCHHHH | 28.61 | - | |
| 80 | Phosphorylation | AAPAAPRSRSLGGAV CCCCCCCCCCCCCHH | 25.76 | 23401153 | |
| 82 | Phosphorylation | PAAPRSRSLGGAVGS CCCCCCCCCCCHHHH | 32.39 | 29255136 | |
| 89 | Phosphorylation | SLGGAVGSVASGARA CCCCHHHHHHHHCCC | 14.12 | 23927012 | |
| 92 | Phosphorylation | GAVGSVASGARAAQS CHHHHHHHHCCCCCC | 30.72 | 23927012 | |
| 99 | Phosphorylation | SGARAAQSPFSIPNS HHCCCCCCCCCCCCC | 24.16 | 26055452 | |
| 102 | Phosphorylation | RAAQSPFSIPNSSSG CCCCCCCCCCCCCCC | 40.29 | 30576142 | |
| 106 | Phosphorylation | SPFSIPNSSSGPYGS CCCCCCCCCCCCCCC | 22.11 | 23401153 | |
| 107 | Phosphorylation | PFSIPNSSSGPYGSQ CCCCCCCCCCCCCCC | 46.05 | 23401153 | |
| 108 | Phosphorylation | FSIPNSSSGPYGSQD CCCCCCCCCCCCCCC | 43.54 | 28348404 | |
| 111 | Phosphorylation | PNSSSGPYGSQDSVH CCCCCCCCCCCCCCC | 32.69 | 22617229 | |
| 113 | Phosphorylation | SSSGPYGSQDSVHSS CCCCCCCCCCCCCCC | 25.60 | 23401153 | |
| 116 | Phosphorylation | GPYGSQDSVHSSPED CCCCCCCCCCCCCCC | 17.69 | 17525332 | |
| 119 | Phosphorylation | GSQDSVHSSPEDGGG CCCCCCCCCCCCCCC | 45.49 | 17525332 | |
| 120 | Phosphorylation | SQDSVHSSPEDGGGG CCCCCCCCCCCCCCC | 19.89 | 26055452 | |
| 135 | Phosphorylation | RDRPVGGSPGGPRLV CCCCCCCCCCCCCEE | 17.91 | 29255136 | |
| 145 | Phosphorylation | GPRLVIGSLPAHLSP CCCEEEECCCCCCCH | 21.76 | 29255136 | |
| 151 | Phosphorylation | GSLPAHLSPHMFGGF ECCCCCCCHHHCCCC | 11.68 | 29255136 | |
| 165 | Ubiquitination | FKCPVCSKFVSSDEM CCCCCCCCCCCCCCC | 44.66 | - | |
| 168 | Phosphorylation | PVCSKFVSSDEMDLH CCCCCCCCCCCCEEE | 34.89 | 24719451 | |
| 169 | Phosphorylation | VCSKFVSSDEMDLHL CCCCCCCCCCCEEEE | 32.08 | 28348404 | |
| 186 | Phosphorylation | CLTKPRITYNEDVLS HHCCCCCCCCHHHHC | 22.90 | 27690223 | |
| 187 | Phosphorylation | LTKPRITYNEDVLSK HCCCCCCCCHHHHCC | 17.74 | 27690223 | |
| 193 | Phosphorylation | TYNEDVLSKDAGECA CCCHHHHCCCCCCCE | 28.47 | 30576142 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
| 145 | S | Phosphorylation | Kinase | MTOR | P42345 | PSP |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of ZNRF2_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of ZNRF2_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| 1433T_HUMAN | YWHAQ | physical | 22797923 | |
| AT1A2_HUMAN | ATP1A2 | physical | 22797923 | |
| UBE2N_HUMAN | UBE2N | physical | 22797923 | |
| ZNRF1_HUMAN | ZNRF1 | physical | 22797923 | |
| UBE2N_HUMAN | UBE2N | physical | 18615712 | |
| UB2E1_HUMAN | UBE2E1 | physical | 18615712 | |
| AT1A1_HUMAN | ATP1A1 | physical | 22797923 | |
| UBC_HUMAN | UBC | physical | 22797923 | |
| MTOR_HUMAN | MTOR | physical | 27244671 | |
| RPTOR_HUMAN | RPTOR | physical | 27244671 | |
| LST8_HUMAN | MLST8 | physical | 27244671 | |
| PPP6_HUMAN | PPP6C | physical | 27244671 | |
| ANR28_HUMAN | ANKRD28 | physical | 27244671 | |
| PP6R3_HUMAN | PPP6R3 | physical | 27244671 | |
| VPP2_HUMAN | ATP6V0A2 | physical | 27244671 | |
| LTOR1_HUMAN | LAMTOR1 | physical | 27244671 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-82; SER-113 AND SER-116,AND MASS SPECTROMETRY. | |
| "Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-19, AND MASSSPECTROMETRY. | |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-82 AND SER-151, AND MASSSPECTROMETRY. | |
| "Combining protein-based IMAC, peptide-based IMAC, and MudPIT forefficient phosphoproteomic analysis."; Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,Yates J.R. III; J. Proteome Res. 7:1346-1351(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-18 AND SER-82, AND MASSSPECTROMETRY. | |
| "ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage."; Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.; Science 316:1160-1166(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-113; SER-116 ANDSER-119, AND MASS SPECTROMETRY. | |
| "Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-135, AND MASSSPECTROMETRY. | |